The U.S. Food & Drug Administration said it is requiring nine medical device companies to conduct postmarket analysis on a connection between needless connectors and higher rates of blood stream infections.
In a notice posted on the Centers for Devices and Radiological Health web site, officials said that the agency is “aware of information that raises concerns about the safety of positive displacement needleless connectors.”